Colin Shannon, EVP, Global Clinical Operations at PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI), sold 71,167 shares at $35.41 ($2.5M) on 2006-10-20, disclosed to the SEC on 2006-10-23.
Open-market sale of $2.5M PPDI by EVP, Global Clinical Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.30 | 22,000 | $777K | 30.8% |
| 2 | $35.35 | 3,000 | $106K | 4.2% |
| 3 | $35.41 | 15,000 | $531K | 21.1% |
| 4 | $35.45 | 11,167 | $396K | 15.7% |
| 5 | $35.49 | 20,000 | $710K | 28.2% |
| Total | $35.40 avg | 71,167 |
| $2.5M |
| 100% |
| Filing → |
| PRAH | SELL | 2021-06-17 | $62.9M | — | Filing → |
| PRAH | SELL | 2021-06-03 | $2.2M | — | Filing → |
| PRAH | SELL | 2020-08-17 | $1.2M | — | Filing → |